vs

Side-by-side financial comparison of FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $44.3M, roughly 1.3× FIRST BUSINESS FINANCIAL SERVICES, INC.). FIRST BUSINESS FINANCIAL SERVICES, INC. runs the higher net margin — 27.5% vs -83.0%, a 110.5% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 8.5%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 8.0%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

FBIZ vs RYTM — Head-to-Head

Bigger by revenue
RYTM
RYTM
1.3× larger
RYTM
$57.3M
$44.3M
FBIZ
Growing faster (revenue YoY)
RYTM
RYTM
+28.4% gap
RYTM
36.9%
8.5%
FBIZ
Higher net margin
FBIZ
FBIZ
110.5% more per $
FBIZ
27.5%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
8.0%
FBIZ

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FBIZ
FBIZ
RYTM
RYTM
Revenue
$44.3M
$57.3M
Net Profit
$12.2M
$-47.5M
Gross Margin
91.6%
Operating Margin
-82.2%
Net Margin
27.5%
-83.0%
Revenue YoY
8.5%
36.9%
Net Profit YoY
9.2%
-9.6%
EPS (diluted)
$1.44
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIZ
FBIZ
RYTM
RYTM
Q1 26
$44.3M
Q4 25
$42.2M
$57.3M
Q3 25
$44.5M
$51.3M
Q2 25
$41.0M
$48.5M
Q1 25
$40.8M
$32.7M
Q4 24
$41.2M
$41.8M
Q3 24
$38.1M
$33.3M
Q2 24
$38.0M
$29.1M
Net Profit
FBIZ
FBIZ
RYTM
RYTM
Q1 26
$12.2M
Q4 25
$13.3M
$-47.5M
Q3 25
$14.4M
$-52.9M
Q2 25
$11.4M
$-46.6M
Q1 25
$11.2M
$-49.5M
Q4 24
$14.4M
$-43.3M
Q3 24
$10.5M
$-43.6M
Q2 24
$10.5M
$-32.3M
Gross Margin
FBIZ
FBIZ
RYTM
RYTM
Q1 26
Q4 25
91.6%
Q3 25
89.3%
Q2 25
88.6%
Q1 25
88.8%
Q4 24
90.9%
Q3 24
88.5%
Q2 24
89.9%
Operating Margin
FBIZ
FBIZ
RYTM
RYTM
Q1 26
Q4 25
38.5%
-82.2%
Q3 25
39.0%
-102.6%
Q2 25
32.6%
-93.4%
Q1 25
33.0%
-143.7%
Q4 24
37.2%
-98.6%
Q3 24
33.8%
-132.0%
Q2 24
32.6%
-139.2%
Net Margin
FBIZ
FBIZ
RYTM
RYTM
Q1 26
27.5%
Q4 25
31.6%
-83.0%
Q3 25
32.3%
-103.1%
Q2 25
27.8%
-96.1%
Q1 25
27.4%
-151.4%
Q4 24
35.0%
-103.6%
Q3 24
27.6%
-131.2%
Q2 24
27.5%
-110.9%
EPS (diluted)
FBIZ
FBIZ
RYTM
RYTM
Q1 26
$1.44
Q4 25
$1.57
$-0.73
Q3 25
$1.70
$-0.82
Q2 25
$1.35
$-0.75
Q1 25
$1.32
$-0.81
Q4 24
$1.69
$-0.71
Q3 24
$1.24
$-0.73
Q2 24
$1.23
$-0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIZ
FBIZ
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$265.8M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$139.1M
Total Assets
$4.3B
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIZ
FBIZ
RYTM
RYTM
Q1 26
$265.8M
Q4 25
$39.5M
$388.9M
Q3 25
$44.3M
$416.1M
Q2 25
$123.2M
$291.0M
Q1 25
$170.6M
$314.5M
Q4 24
$157.7M
$320.6M
Q3 24
$132.0M
$298.4M
Q2 24
$81.1M
$319.1M
Stockholders' Equity
FBIZ
FBIZ
RYTM
RYTM
Q1 26
Q4 25
$371.6M
$139.1M
Q3 25
$358.3M
$148.8M
Q2 25
$344.8M
$-11.9M
Q1 25
$336.1M
$18.9M
Q4 24
$328.6M
$21.7M
Q3 24
$312.0M
$11.2M
Q2 24
$305.2M
$39.3M
Total Assets
FBIZ
FBIZ
RYTM
RYTM
Q1 26
$4.3B
Q4 25
$4.1B
$480.2M
Q3 25
$4.0B
$506.9M
Q2 25
$4.0B
$372.7M
Q1 25
$3.9B
$386.7M
Q4 24
$3.9B
$392.3M
Q3 24
$3.7B
$363.6M
Q2 24
$3.9B
$381.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIZ
FBIZ
RYTM
RYTM
Operating Cash FlowLast quarter
$-25.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIZ
FBIZ
RYTM
RYTM
Q1 26
Q4 25
$61.7M
$-25.4M
Q3 25
$18.4M
$-26.6M
Q2 25
$15.8M
$-23.3M
Q1 25
$11.3M
$-40.4M
Q4 24
$57.5M
$-18.8M
Q3 24
$13.8M
$-25.2M
Q2 24
$13.1M
$-29.1M
Free Cash Flow
FBIZ
FBIZ
RYTM
RYTM
Q1 26
Q4 25
$61.1M
Q3 25
$18.3M
Q2 25
$15.5M
Q1 25
$11.2M
Q4 24
$57.3M
Q3 24
$13.2M
Q2 24
$12.7M
FCF Margin
FBIZ
FBIZ
RYTM
RYTM
Q1 26
Q4 25
144.7%
Q3 25
41.0%
Q2 25
37.8%
Q1 25
27.5%
Q4 24
139.2%
Q3 24
34.6%
Q2 24
33.3%
Capex Intensity
FBIZ
FBIZ
RYTM
RYTM
Q1 26
Q4 25
1.4%
Q3 25
0.3%
Q2 25
0.8%
Q1 25
0.2%
Q4 24
0.5%
Q3 24
1.6%
Q2 24
1.1%
Cash Conversion
FBIZ
FBIZ
RYTM
RYTM
Q1 26
Q4 25
4.63×
Q3 25
1.28×
Q2 25
1.39×
Q1 25
1.01×
Q4 24
3.99×
Q3 24
1.31×
Q2 24
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons